News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CollaGenex Pharmaceuticals, Inc. (CGPI) Files Patent Infringement Claim Against IVAX Pharmaceuticals, Inc. (IVX) And CorePharma LLC


10/19/2005 5:11:44 PM

CollaGenex Pharmaceuticals, Inc. (Nasdaq:CGPI) today announced that it has filed a complaint for patent infringement against IVAX Pharmaceuticals Inc. and CorePharma LLC ("Defendants") in the United States District Court for the Eastern District of New York. CollaGenex alleges that the Defendants' submissions of Abbreviated New Drug Applications ("ANDA's") covering their 20mg tablets of doxycycline hyclate infringe United States Patent RE 34,656, of which CollaGenex is the exclusive licensee. CollaGenex is seeking an injunction preventing the Defendants from introducing 20mg tablets of doxycycline hyclate into the market in the United States.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES